Evaluating proposals
Innovative therapies for skin diseases
Maximising the value of your preclinical assets to find a breakthrough therapy for patients.
Our Aim
We are looking for partnering opportunities on new assets (small molecules, biologics or advanced therapies) in research or preclinical development stages that could be useful for the treatment of dermatological diseases.
Preferably, the assets should target immuno-inflammatory pathways or be suitable for dermato-oncological or rare skin indications, and demonstrate strong scientific rationale, including in vitro and in vivo evidences of efficacy, if available.
Our interest
New assets in advanced research or preclinical development stages
What we offer
Access to our expertise in dermatological R&D
Your benefit
Funding and partnership opportunity
Shared goal
Finding innovative therapies for patients
Who is this for?
Universities
Biotechs
Public and private research institutions
Start-ups
Pharmaceutical companies
For scientists at Universities, research institutions, biotechs, start-ups and pharmaceutical companies
Open from 05/07/21 to 06/11/21
Funding & partnership opportunity
Collaborative framework
Submitted proposals may be eligible for funding and a research or preclinical development partnership
You will retain ownership of any intellectual property you may bring or develop
Assets might be characterised on key dermatological in vitro and in vivo assays
A designated contact person will help answer your questions
Submitted proposals may be eligible for funding and a research or preclinical development partnership
You will retain ownership of any intellectual property you may bring or develop
Assets might be characterised on key dermatological in vitro and in vivo assays
A designated contact person will help answer your questions
Collaboration process
Collaboration process
1
Proposal submission
From July 5th, 2021 to October 31st, 2021
2
Submissions will be handled following all applicable local compliance requirements
3
Proposal evaluation and selection
Within 4-8 weeks after submission
